Select Medical (NYSE:SEM) Updates FY 2026 Earnings Guidance

Select Medical (NYSE:SEM) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 1.220-1.320 for the period, compared to the consensus EPS estimate of 1.320. The company issued revenue guidance of $5.6 billion-$5.8 billion, compared to the consensus revenue estimate of $5.6 billion.

Analysts Set New Price Targets

Several analysts have recently commented on SEM shares. Wall Street Zen upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Weiss Ratings reissued a “sell (d+)” rating on shares of Select Medical in a report on Wednesday, January 21st. Benchmark reissued a “buy” rating on shares of Select Medical in a research note on Monday, October 27th. Finally, Mizuho set a $17.00 price target on shares of Select Medical in a report on Monday, November 3rd. Four research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Select Medical presently has an average rating of “Moderate Buy” and a consensus target price of $17.80.

Select Medical Trading Down 1.5%

NYSE SEM traded down $0.25 during mid-day trading on Thursday, hitting $16.07. The company’s stock had a trading volume of 1,243,008 shares, compared to its average volume of 700,650. The stock’s fifty day simple moving average is $15.30 and its two-hundred day simple moving average is $14.03. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.09 and a quick ratio of 1.09. Select Medical has a 52-week low of $11.65 and a 52-week high of $19.40. The firm has a market capitalization of $1.99 billion, a P/E ratio of 18.69, a price-to-earnings-growth ratio of 0.57 and a beta of 1.25.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, February 19th. The health services provider reported $0.16 EPS for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.07). Select Medical had a return on equity of 7.41% and a net margin of 2.05%.Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Research analysts expect that Select Medical will post 1.17 EPS for the current year.

Institutional Trading of Select Medical

A number of institutional investors and hedge funds have recently modified their holdings of the business. Graham Capital Management L.P. bought a new stake in shares of Select Medical during the fourth quarter valued at approximately $154,000. Brooklyn Investment Group bought a new stake in Select Medical in the fourth quarter valued at approximately $161,000. CIBC Bancorp USA Inc. acquired a new stake in Select Medical in the third quarter worth $153,000. iSAM Funds UK Ltd bought a new position in shares of Select Medical during the third quarter worth $96,000. Finally, Entropy Technologies LP bought a new stake in shares of Select Medical in the 3rd quarter valued at $177,000. 89.48% of the stock is owned by institutional investors and hedge funds.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.